(Q44765904)

6 December 2017

title

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327789

14 September 2022

2

M. E. Erwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327789

14 September 2022

author name string

H. S. Sader

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327789

14 September 2022

R. N. Jones

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327789

14 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1327789

14 September 2022

publication date

1 April 1992

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

6 December 2017

published in

1 reference

6 December 2017

volume

11

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

372-381

1 reference

Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01962081

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962081

In vitro and in vivo antibacterial activity of AT-2266.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962081

In vitro and in vivo activity of DL-8280, a new oxazine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962081

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962081

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01962081

Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia

21 January 2018

1 reference

12 December 2020

Comparative in vitro activity of quinolones.

1 reference

12 December 2020

In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline

1 reference

12 December 2020

Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae

1 reference

12 December 2020

Use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae

1 reference

12 December 2020

Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01962081

1 reference

6 December 2017

1 reference